(Q46738451)

24 December 2017

title

Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children (English)

1 reference

24 December 2017

1 reference

1

Hengameh H Raissy

1 reference

24 December 2017

author name string

Michelle Harkins

series ordinal

2

1 reference

24 December 2017

Franceska Kelly

series ordinal

3

1 reference

24 December 2017

H William Kelly

series ordinal

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

24 December 2017

published in

Pharmacotherapy

1 reference

24 December 2017

volume

28

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

287-294

1 reference

24 December 2017

Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Increased leukotrienes in exhaled breath condensate in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Exhaled breath condensate eicosanoids and sputum eosinophils in asthmatic children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Time efficacy of a single dose of montelukast on exercise-induced asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Airway immunopathology of asthma with exercise-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.3.287

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.3.287

1 reference

24 December 2017

1 reference

24 December 2017